Literature DB >> 17110058

Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city.

Susan G Sherman1, Yingkai Cheng, Alexander H Kral.   

Abstract

OBJECTIVES: The current study examines the prevalence and correlates of witnessing and experiencing opiate overdoses among a sample of young, injection drug users (IDUs) and non-injection drug users (NIDUs) in Baltimore, MD.
METHODS: Data were derived from a longitudinal study of 15-30 year old IDUs and NIDUs (N=309) who had initiated heroin, cocaine, and/or crack use within 5 years prior to study enrollment. Chi-square and Wilcoxon rank-sum tests were used in bivariate analyses of demographic and drug use variables with each of the two dependent variables. Multivariate logistic regression models were used to identify correlates of experiencing and witnessing overdose.
RESULTS: Twenty-nine percent of participants reported having ever experienced an opiate overdose and 57% reported having ever witnessed an overdose. Having ever experienced an opiate overdose was independently associated with being White (Adjusted Odds Ratio [AOR]=3.2; 95% Confidence Interval [CI]: 1.6, 6.4) recent homelessness (AOR=2.9; 95%CI: 1.5, 5.7); and length of injection, 5.6-6.9 years versus <5.6 years (AOR=4.0; 95%CI: 1.8-8.9); injecting 7.0-7.9 years versus <5.6 years (AOR=2.5; 95%CI: 1.03-6.1); injecting >8 versus <5.6 years (AOR=4.7; 95%CI: 2.2-10.2). Having witnessed an opiate overdose was independently associated with being White (AOR=2.4; 95%CI: 1.4, 4.1) and injecting >8 years versus <5.6 years (AOR=2.2; 95%CI: 1.2, 4.0).
CONCLUSIONS: This study documents the high prevalence of witnessing and experiencing opiate overdoses among young, newly initiated IDUs and NIDUs. The results could inform the growing number of overdose prevention efforts throughout the U.S.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110058      PMCID: PMC1950747          DOI: 10.1016/j.drugalcdep.2006.10.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  41 in total

1.  Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco.

Authors:  A H Kral; J Lorvick; B R Edlin
Journal:  J Acquir Immune Defic Syndr       Date:  2000-06-01       Impact factor: 3.731

2.  Causes of death in hospitalized intravenous drug abusers.

Authors:  E C Klatt; N Z Mills; T T Noguchi
Journal:  J Forensic Sci       Date:  1990-09       Impact factor: 1.832

3.  The first hit: circumstances surrounding initiation into injecting.

Authors:  N Crofts; R Louie; D Rosenthal; D Jolley
Journal:  Addiction       Date:  1996-08       Impact factor: 6.526

4.  Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings.

Authors:  M Gossop; P Griffiths; B Powis; S Williamson; J Strang
Journal:  BMJ       Date:  1996-08-17

5.  Mortality among injecting drug users: a critical reappraisal.

Authors:  M Frischer; M Bloor; D Goldberg; J Clark; S Green; N McKeganey
Journal:  J Epidemiol Community Health       Date:  1993-02       Impact factor: 3.710

6.  Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose.

Authors:  S Darke; J Ross; W Hall
Journal:  Addiction       Date:  1996-03       Impact factor: 6.526

7.  Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study.

Authors:  E Oppenheimer; C Tobutt; C Taylor; T Andrew
Journal:  Addiction       Date:  1994-10       Impact factor: 6.526

8.  Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users.

Authors:  E J van Ameijden; J A van den Hoek; C Hartgers; R A Coutinho
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

9.  The consistency of self-reported HIV risk behavior among injection drug users.

Authors:  K McElrath; D D Chitwood; D K Griffin; M Comerford
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

10.  Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users.

Authors:  M Davoli; C A Perucci; F Forastiere; P Doyle; E Rapiti; M Zaccarelli; D D Abeni
Journal:  Int J Epidemiol       Date:  1993-04       Impact factor: 7.196

View more
  37 in total

1.  Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically.

Authors:  Alexandria Macmadu; Jennifer J Carroll; Scott E Hadland; Traci C Green; Brandon D L Marshall
Journal:  Addict Behav       Date:  2017-01-06       Impact factor: 3.913

2.  Correlates of overdose risk perception among illicit opioid users.

Authors:  Christopher Rowe; Glenn-Milo Santos; Emily Behar; Philip O Coffin
Journal:  Drug Alcohol Depend       Date:  2015-12-30       Impact factor: 4.492

3.  Risk Factors for Overdose in Young People Who Received Substance Use Disorder Treatment.

Authors:  Amy M Yule; Nicholas W Carrellas; Maura DiSalvo; Rachael M Lyons; James W McKowen; Jessica E Nargiso; Brandon G Bergman; John F Kelly; Timothy E Wilens
Journal:  Am J Addict       Date:  2019-07-10

4.  Correlates and contexts of US injection drug initiation among undocumented Mexican migrant men who were deported from the United States.

Authors:  Angela M Robertson; Remedios Lozada; Robin A Pollini; Gudelia Rangel; Victoria D Ojeda
Journal:  AIDS Behav       Date:  2012-08

5.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

6.  Law enforcement attitudes toward overdose prevention and response.

Authors:  Traci C Green; Nickolas Zaller; Wilson R Palacios; Sarah E Bowman; Madeline Ray; Robert Heimer; Patricia Case
Journal:  Drug Alcohol Depend       Date:  2013-09-02       Impact factor: 4.492

7.  Individual and network factors associated with non-fatal overdose among rural Appalachian drug users.

Authors:  Jennifer R Havens; Carrie B Oser; Hannah K Knudsen; Michelle Lofwall; William W Stoops; Sharon L Walsh; Carl G Leukefeld; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

8.  Impact of incarceration experiences on reported HIV status and associated risk behaviours and disease comorbidities.

Authors:  Robert Heimer; Olga S Levina; Victoria Osipenko; Monica S Ruiz; Boris Sergeyev; Aleksander V Sirotkin; Inna Vyshemirskaya
Journal:  Eur J Public Health       Date:  2015-09-16       Impact factor: 3.367

9.  Overdose prevention and naloxone prescription for opioid users in San Francisco.

Authors:  Lauren Enteen; Joanna Bauer; Rachel McLean; Eliza Wheeler; Emalie Huriaux; Alex H Kral; Joshua D Bamberger
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

10.  Can abuse deterrent formulations make a difference? Expectation and speculation.

Authors:  Simon H Budman; Jill M Grimes Serrano; Stephen F Butler
Journal:  Harm Reduct J       Date:  2009-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.